These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7533967)

  • 1. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines.
    Shouval D; Ilan Y; Adler R; Deepen R; Panet A; Even-Chen Z; Gorecki M; Gerlich WH
    Vaccine; 1994 Nov; 12(15):1453-9. PubMed ID: 7533967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children.
    Raz R; Dagan R; Gallil A; Brill G; Kassis I; Koren R
    Vaccine; 1996 Feb; 14(3):207-11. PubMed ID: 8920701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults.
    Raz R; Koren R; Bass D
    Isr Med Assoc J; 2001 May; 3(5):328-32. PubMed ID: 11411195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates.
    Yerushalmi B; Raz R; Blondheim O; Shumov E; Koren R; Dagan R
    Pediatr Infect Dis J; 1997 Jun; 16(6):587-92. PubMed ID: 9194109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the T- and B-cell immune response to a new recombinant pre-S1, pre-S2 and SHBs antigen containing hepatitis B vaccine (Hepagene); evidence for superior anti-SHBs antibody induction in responder mice.
    Jones CD; Page M; Bacon A; Cahill E; Bentley M; Chatfield SN
    J Viral Hepat; 1998 Nov; 5 Suppl 2():5-8. PubMed ID: 9857353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell and antibody response characterisation of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing hepatitis B vaccine; demonstration of superior anti-SHBs antibody induction in responder mice.
    Jones CD; Page M; Bacon A; Cahill E; Bentley M; Chatfield SN
    Vaccine; 1999 Jun; 17(20-21):2528-37. PubMed ID: 10418899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus vaccination for older adults.
    Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
    J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.
    Shouval D; Roggendorf H; Roggendorf M
    Med Microbiol Immunol; 2015 Feb; 204(1):57-68. PubMed ID: 25557605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine.
    Shapira MY; Zeira E; Adler R; Shouval D
    J Hepatol; 2001 Jan; 34(1):123-7. PubMed ID: 11211888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
    Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
    Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a new type of yeast-derived hepatitis B vaccine consisting of M (pre-S2 + S) protein particles.
    Hazama M; Takaoki M; Ohfune K; Hinuma S; Fujisawa Y
    Vaccine; 1989 Dec; 7(6):567-73. PubMed ID: 2532813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a 'pre-S2 plus S' hepatitis B vaccine in healthy adults.
    Katkov WN; Watkins E; DeMelia HC; Dienstag JL
    J Viral Hepat; 1994; 1(1):79-83. PubMed ID: 8790563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.
    Niedre-Otomere B; Bogdanova A; Skrastina D; Zajakina A; Bruvere R; Ose V; Gerlich WH; Garoff H; Pumpens P; Glebe D; Kozlovska T
    J Viral Hepat; 2012 Sep; 19(9):664-73. PubMed ID: 22863271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizations.
    Geissler M; Bruss V; Michalak S; Hockenjos B; Ortmann D; Offensperger WB; Wands JR; Blum HE
    J Virol; 1999 May; 73(5):4284-92. PubMed ID: 10196326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene, a hepatitis B vaccine containing pre-S1, pre-S2 gene products.
    Pride MW; Bailey CR; Muchmore E; Thanavala Y
    Vaccine; 1998 Apr; 16(6):543-50. PubMed ID: 9569463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel, recombinant triple antigen hepatitis B vaccine (Hepacare).
    Page M; Jones CD; Bailey C
    Intervirology; 2001; 44(2-3):88-97. PubMed ID: 11509870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactogenicity and immunogenicity of a new recombinant hepatitis B vaccine containing Pre S antigens: a preliminary report.
    Hourvitz A; Mosseri R; Solomon A; Yehezkelli Y; Atsmon J; Danon YL; Koren R; Shouval D
    J Viral Hepat; 1996 Jan; 3(1):37-42. PubMed ID: 8736239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
    Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines.
    Yap I; Guan R; Chan SH
    J Gastroenterol Hepatol; 1995; 10(1):51-5. PubMed ID: 7620108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 5-year immunization field trial against hepatitis B using a Chinese hamster ovary cell recombinant vaccine in French Polynesian newborns: results at 3 years.
    Moulia-Pelat JP; Spiegel A; Martin PM; Cardines R; Boutin JP; Roux JF; Excler JL; Saliou P
    Vaccine; 1994 May; 12(6):499-502. PubMed ID: 8036822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.